Diagnostic Value of Nutritional Risk Index and Other Indices for Predicting Sarcopenia in the Middle-Aged and Elderly Population of China Without Cancer: A ROC Curve Analysis
Jing-Feng Zou,Shao-Tian Li,Li-Ping Wang,Nian-Li Zhou,Jia-Jia Ran,Xin Yang,Chun-Hui Tian,Yi-Ting Liu,Yun Liu,Wen Peng
DOI: https://doi.org/10.2147/ijgm.s457252
IF: 2.145
2024-06-01
International Journal of General Medicine
Abstract:Jing-Feng Zou, &ast Shao-Tian Li, &ast Li-Ping Wang, &ast Nian-Li Zhou, Jia-Jia Ran, Xin Yang, Chun-Hui Tian, Yi-Ting Liu, Yun Liu, Wen Peng Department of General Practice, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, WuHan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yun Liu; Wen Peng, Department of General Practice, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue, WuHan, Hubei, 1227, People's Republic of China, Email ; Background: Emerging evidence suggests that systemic inflammatory and nutritional biomarkers, along with derived indices, could serve as predictors for sarcopenia in cancer population. This study aimed to compare these predictors, focusing on the nutritional risk index (NRI) and evaluate its diagnostic value, for sarcopenic patients without cancer. Methods: This cross-sectional retrospective study included 1674 participants. Sarcopenia is defined by skeletal muscle mass index (SMI). Laboratory data reflected the values of systemic inflammatory and nutritional biomarkers, from which the derived indices were calculated. Multiple logistic regression analysis, ROC curve analysis, and the Youden index were utilized to assess the association between these markers and sarcopenia and determine the cutoff value for predicting sarcopenia. Results: Among all participants (1110 men and 564 women, mean age 61.97 ± 9.83 years), 398 individuals were diagnosed with sarcopenia, indicating a prevalence of 23.78% in China's middle-aged and elderly population without cancer. Logistic regression analysis revealed significant associations between all biomarkers and derived indices with sarcopenia. Following adjustment for potential confounders, lower NRI values were significantly associated with a higher incidence of sarcopenia. For sarcopenia diagnosis, the area under the curve (AUC) for NRI was 0.769 ([95% CI, 0.742, 0.796], P < 0.001), with a cutoff value of 106.016, sensitivity of 75.6% and specificity of 66.1%. NRI demonstrated greater predictive advantage for sarcopenia incidence in men compared to women. Conclusion: A lower NRI value was associated with a higher prevalence of sarcopenia. NRI shows promise for early, rapid, and effective sarcopenia screening, particularly in China's middle-aged and elderly male population without cancer. Keywords: sarcopenia, systemic inflammation, nutritional risk index, NRI Sarcopenia is a chronic, progressive, and systemic disease affecting skeletal muscle, primarily characterized by the loss of skeletal muscle mass (SMM), strength, and function. This condition significantly increases the risk of adverse outcomes associated with falls, functional decline, frailty, and mortality. 1 Individuals with sarcopenia experience a notably lower health-related quality of life (HRQoL) compared to those without the condition. 2 The prevalence of sarcopenia has escalated in tandem with the aging population, with pooled estimates ranging from 9.9% to 40.4%. 3 A previous study of ours confirmed a sarcopenia prevalence of 15.34% among patients undergoing health check-ups. 4 The molecular mechanisms underlying sarcopenia are multifactorial and include causes such as inflammation, mitochondrial dysfunction, and imbalances in protein metabolism. 5,6 While the exact molecular pathways remain unclear, inflammation and inflammatory cytokines (CRP, IL-6, TNF-α) are believed to play a crucial role in the progression of sarcopenia. 7–9 Inflammation, a major clinical characteristic, is shared by sarcopenia and cachexia in cancer, alongside the loss of muscle mass, strength, and function. 10 Cancer patients are particularly susceptible to developing sarcopenia due to inflammation, leading to a higher incidence of postoperative complications and poorer overall survival. Inflammatory and nutritional biomarkers have shown predictive value in this population. For instance, a higher platelet-to lymphocyte-ratio (PLR) is associated with a 2.36 times greater risk of sarcopenia in the elderly. 11 PLR and neutrophil-to-lymphocyte ratio (NLR) have also been positively correlated with sarcopenia in urologic carcinoma patients. 12,13 Additionally, the lymphocyte-to-monocyte ratio (LMR) has been linked to a poor prognosis in non-metastatic breast cancer patients. 14 Studies have shown that the systemic immune inflammation index (SII) is positively correlated with sarcopenia and sarcopenic obesity, serving as an independent prognostic indicator for poor prognosis in gastric cancer patients. 15,16 Sim -Abstract Truncated-
medicine, general & internal